Advanced search
Publication Cover
Journal of Blood Medicine Volume 14, 2023 - Issue
Submit an article Journal homepage
96
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Predictors of Intensive Care Admission Among Adult Patients with Sickle Cell Disease in Eastern Province of Saudi Arabia

Mortadah Alsalman1 Department of Medicine, College of Medicine, King Faisal University, Alahsa, Saudi ArabiaORCID Iconhttps://orcid.org/0000-0003-3975-5550View further author information
ORCID Icon,
Zaenb Alsalman2 Department of Family and Community Medicine, College of Medicine, King Faisal University, Alahsa, Saudi ArabiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1008-7977View further author information
ORCID Icon,
Hussain Abduljaleel Alkhalifa3 Department of Medicine, King Fahad Specialist Hospital, Dammam, Saudi ArabiaORCID Iconhttps://orcid.org/0000-0002-4709-5030View further author information
ORCID Icon,
Aman N Alfaraj3 Department of Medicine, King Fahad Specialist Hospital, Dammam, Saudi ArabiaView further author information
,
Ali Alkhalifah4 Emergency Department, Eastern Health Cluster, Dammam, Saudi ArabiaORCID Iconhttps://orcid.org/0000-0002-6744-2626View further author information
ORCID Icon &
Qasem Almulihi5 Emergency Department, King Fahad University Hospital, Al Khobar, Saudi ArabiaORCID Iconhttps://orcid.org/0000-0001-6341-0910View further author information
ORCID Icon
Pages 671-680 | Received 17 Aug 2023, Accepted 21 Dec 2023, Published online: 26 Dec 2023

References

  • Ware RE, de Montalembert M, Tshilolo L, Abboud MR. Sickle cell disease. In: The Lancet. Vol. 390. Lancet Publishing Group; 2017:311–323.
  • Jastaniah W. Epidemiology of sickle cell disease in Saudi Arabia. Annals of Saudi Medicine. 2011;31(3):289–293. doi:10.4103/0256-4947.81540
  • Houwing ME, de Pagter PJ, van Beers EJ, et al. Sickle cell disease: Clinical presentation and management of a global health challenge. In: Blood Reviews. Vol 37. Churchill Livingstone; 2019.
  • Ribeil JA, Hacein-Bey-Abina S, Payen E, et al. Gene therapy in a patient with sickle cell disease. New England Journal of Medicine. 2017;376(9):848–855. doi:10.1056/NEJMoa1609677
  • Lubeck D, Agodoa I, Bhakta N, et al. estimated life expectancy and income of patients with sickle cell disease compared with those without sickle cell disease. JAMA Netw Open. 2019;2(11):e1915374. doi:10.1001/jamanetworkopen.2019.15374
  • Cecchini J, Lionnet F, Djibré M, et al. Outcomes of adult patients with sickle cell disease admitted to the ICU: a case series. Crit Care Med. 2014;42(7):1629–1639. doi:10.1097/CCM.0000000000000316
  • Al Khawaja SA, Ateya ZM, Al Hammam RA. Predictors of mortality in adults with Sickle cell disease admitted to intensive care unit in Bahrain. J Crit Care. 2017;42:238–242. doi:10.1016/j.jcrc.2017.07.032
  • McGann PT, Ware RE. Hydroxyurea for sickle cell anemia: what have we learned and what questions still remain? Curr Opin Hematol. 2011;18(3):158–165. doi:10.1097/MOH.0b013e32834521dd
  • Carden MA, Little J. Emerging disease-modifying therapies for sickle cell disease. In: Haematologica. Vol. 104. Ferrata Storti Foundation; 2019:1710–1719.
  • Shah N, Beenhouwer D, Broder MS, et al. Development of a severity classification system for sickle cell disease. ClinicoEconomics and Outcomes Research. 2020;12:625–633. doi:10.2147/CEOR.S276121
  • Steinberg MH, Sebastiani P. Genetic modifiers of sickle cell disease. American Journal of Hematology. 2012;87(8):795–803. doi:10.1002/ajh.23232
  • Jagadeeswaran R, Rivers A. Evolving treatment paradigms in sickle cell disease. Hematology. 2017;2017(1):440–446. doi:10.1182/asheducation-2017.1.440
  • Mak V, Davies SC. The pulmonary physician in critical care • Illustrative case 6: acute chest syndrome of sickle cell anaemia. Thorax. 2003;58(58):726–728. doi:10.1136/thorax.58.8.726
  • John CC, Opoka RO, Latham TS, et al. Hydroxyurea dose escalation for sickle cell anemia in sub-saharan Africa. New England Journal of Medicine. 2020;382(26):2524–2533. doi:10.1056/NEJMoa2000146
  • Hermans G, Van Aerde N, Meersseman P, et al. Five-year mortality and morbidity impact of prolonged versus brief ICU stay: a propensity score matched cohort study. Thorax. 2019;74(11):1037–1045. doi:10.1136/thoraxjnl-2018-213020
  • Mekontso Dessap A, Fartoukh M, Machado RF. Ten tips for managing critically ill patients with sickle cell disease. Intensive Care Med. 2017;43(1):80–82. doi:10.1007/s00134-016-4472-7
  • Tawfic QA, Kausalya R, Al-Sajee D, Burad J, Mohammed AK, Narayanan A. Adult sickle cell disease: a five-year experience of intensive care management in a university hospital in Oman. Sultan Qaboos Univ Med J. 2012;12(2):177–183. doi:10.12816/0003110
  • Howard J, Hart N, Roberts-Harewood M, Cummins M, Awogbade M, Davis B. Guideline on the management of acute chest syndrome in sickle cell disease. Br J Haematol. 2015;169(4):492–505. doi:10.1111/bjh.13348
  • Linder GE, Chou ST. Red cell transfusion and alloimmunization in sickle cell disease. In: Haematologica. Vol. 106. Ferrata Storti Foundation; 2021:1805–1815.
  • Agbakou M, Mekontso-Dessap A, Pere M, et al. Nationwide retrospective study of critically ill adults with sickle cell disease in France. Sci Rep. 2021;11(1). doi:10.1038/s41598-021-02437-2
  • Shome D, Jaradat A, Mahozi A, et al. The platelet count and its implications in sickle cell disease patients admitted for intensive care. Indian J Crit Care Med. 2018;22(8):585–590. doi:10.4103/ijccm.IJCCM_49_18
  • Hogg PJ. TMX1: a new vascular thiol isomerase. Blood. 2019;133(3):188–190. doi:10.1182/blood-2018-11-887679

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.